Literature DB >> 27517250

A bioassay for parathyroid hormone and other substances affecting bone metabolism.

J McPartlin1, D Powell1.   

Abstract

A bioassay method for measuring parathyroid hormone (PTH) and other substances that influence bone metabolism is described. Monolayers of bone cells are culturedin vitro, then treated with the test material. Biological activity is determined by measuring the resulting rise in bone-cell adenosine 3',5'-monophosphate (cAMP).Treatment with PTH (1-500 ng/ml) produced a dose-dependent increase in bone-cell cyclic AMP levels. Treatment with prostaglandin E2 also caused an elevation in bone-cell cyclic AMP level, whereas oestradiol inhibited the effect of PTH. High calcium concentration inhibited the stimulatory effect of PTH on bone-cell cyclic AMP; variations in phosphate and magnesium concentrations were without effect. Biological activity was demonstrated in various unextracted normal and hypercalcaemic sera.

Entities:  

Year:  1976        PMID: 27517250     DOI: 10.1007/BF02938966

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  36 in total

1.  BONE CELLS: BIOCHEMICAL AND BIOLOGICAL STUDIES AFTER ENZYMATIC ISOLATION.

Authors:  W A PECK; S J BIRGE; S A FEDAK
Journal:  Science       Date:  1964-12-11       Impact factor: 47.728

2.  A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture.

Authors:  D Atkins; M Peacock
Journal:  J Endocrinol       Date:  1975-03       Impact factor: 4.286

3.  The effect of parathyroid hormone and thyrocalcitonin on the accumulation of cyclic adenosine 3':5'-monophosphate in freshly isolated bone cells.

Authors:  S B Rodan; G A Rodan
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

4.  Avian bioassay method for parathyroid hormone.

Authors:  C G Dacke; A D Kenny
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

5.  A chick bioassay for parathyroid hormone.

Authors:  J A Parsons; B Reit; C J Robinson
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

6.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

Authors:  B L Riggs; J Jowsey; R S Goldsmith; P J Kelly; D L Hoffman; C D Arnaud
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

7.  Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.

Authors:  J C Gallagher; B E Nordin
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

8.  Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.

Authors:  H D Brereton; P V Halushka; R W Alexander; D M Mason; H R Keiser; V T DeVita
Journal:  N Engl J Med       Date:  1974-06-11       Impact factor: 91.245

9.  Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness.

Authors:  H Estep; W A Shaw; C Watlington; R Hobe; W Holland; S G Tucker
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

10.  Pathogenesis of hypocalcemia in magnesium depletion. Normal end-organ responsiveness to parathyroid hormone.

Authors:  S M Suh; A Csima; D Fraser
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  2 in total

1.  Cyclic AMP as a second messenger in the skeletal actions of parathyroid hormone: a decade-old hypothesis.

Authors:  W A Peck
Journal:  Calcif Tissue Int       Date:  1979-11       Impact factor: 4.333

2.  Thin bone (osteoporosis) and hormones.

Authors:  D Powell; D O'Keeffe
Journal:  Ir J Med Sci       Date:  1983-07       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.